Testing QLS5132 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug, QLS5132, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors that have spread or cannot be removed by surgery.
- Your tumors can be measured on scans (RECIST criteria).
- You are able to be up and around (ECOG score 0 or 1).
- Your major organs (like liver, kidney, bone marrow) are working well enough.
- You have recovered from any significant side effects of previous cancer treatments (except for hair loss or mild nerve pain).
- You have not been treated with drugs targeting a protein called CLDN6 or with a type of drug called a topoisomerase I inhibitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS5133 for people with advanced solid tumors that have not responded to other treatments. The drug is given alone, and the study aims to see if it is safe and effective.
This Phase 1 trial tests the safety and how the medicine works in the body, and also looks at early signs of effectiveness. It is for adults with advanced solid tumors, and for Phase 1b specifically, the tumor must show a marker called GPC3.
This trial tests a new drug called QLS5132, alone or in combination, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can shrink tumors or slow their growth.
This Phase 1 trial studies QLP2117, a new treatment, in people with advanced solid tumors that have come back or didn’t respond to standard care. It mainly looks at safety and how the body handles the drug, and it may help find a dose worth further study.
This trial tests a new drug called QLM2011 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests an experimental drug, QLS-1304, for people with advanced solid tumors that have stopped responding to standard treatment. The goal is to see if the drug is safe and effective.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.